Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura N Burga

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|June 27, 2017
Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virusLinde A Miles, Laura N Burga, Eric E Gardner, et al.
Mbio|August 14, 2020
Visualizing Nudivirus Assembly and EgressSailakshmi Velamoor, Allan Mitchell, Bruno M Humbel, et al.
Molecular Cancer|December 17, 2008
Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stabilityPrudence B Lam, Laura N Burga, Bryan P Wu, et al.
Journal of Structural Biology|October 7, 2023
Beyond the surface: Investigation of tumorsphere morphology using volume electron microscopyNickhil Jadav, Sailakshmi Velamoor, Daniel Huang, et al.
Breast Cancer Research : BCR|March 15, 2011
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant miceLaura N Burga, Hai Hu, Ashish Juvekar, et al.
Journal of Virology|August 20, 2025
Cryo-EM structure of the Seneca Valley virus A-particle and related structural statesRosheny Kumaran, Nadishka Jayawardena, Kuan-Lin Chen, et al.
Plos Pathogens|May 28, 2024
Variation in structural motifs within SARS-related coronavirus spike proteinsFrancesca R Hills, Alice-Roza Eruera, James Hodgkinson-Bean, et al.
Cancer Research|February 5, 2009
Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriersLaura N Burga, Nadine M Tung, Susan L Troyan, et al.
Cancer Discovery|August 24, 2012
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancerAshish Juvekar, Laura N Burga, Hai Hu, et al.
Cell|October 15, 2013
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cellsWilliam J Israelsen, Talya L Dayton, Shawn M Davidson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|June 27, 2017
Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virusLinde A Miles, Laura N Burga, Eric E Gardner, et al.
Mbio|August 14, 2020
Visualizing Nudivirus Assembly and EgressSailakshmi Velamoor, Allan Mitchell, Bruno M Humbel, et al.
Molecular Cancer|December 17, 2008
Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stabilityPrudence B Lam, Laura N Burga, Bryan P Wu, et al.
Journal of Structural Biology|October 7, 2023
Beyond the surface: Investigation of tumorsphere morphology using volume electron microscopyNickhil Jadav, Sailakshmi Velamoor, Daniel Huang, et al.
Breast Cancer Research : BCR|March 15, 2011
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant miceLaura N Burga, Hai Hu, Ashish Juvekar, et al.
Journal of Virology|August 20, 2025
Cryo-EM structure of the Seneca Valley virus A-particle and related structural statesRosheny Kumaran, Nadishka Jayawardena, Kuan-Lin Chen, et al.
Plos Pathogens|May 28, 2024
Variation in structural motifs within SARS-related coronavirus spike proteinsFrancesca R Hills, Alice-Roza Eruera, James Hodgkinson-Bean, et al.
Cancer Research|February 5, 2009
Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriersLaura N Burga, Nadine M Tung, Susan L Troyan, et al.
Cancer Discovery|August 24, 2012
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancerAshish Juvekar, Laura N Burga, Hai Hu, et al.
Cell|October 15, 2013
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cellsWilliam J Israelsen, Talya L Dayton, Shawn M Davidson, et al.
Pageof 2